XVIVO Perfusion AB: CORRECTION: XVIVO's Innovative Preservation Technology Used in the World's First Ever Successful Heart Xenotransplantation (Pig to Human)
This correction is to reflect an updated link to the University of Maryland School of Medicine homepageGOTHENBURG, SWEDEN / ACCESSWIRE / January 10, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)On